G/TBT/N/RUS/129  
17 March 2022  
(22-2359) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  RUSSIAN FEDERATION   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:   
Eurasian Economic Commission  
Department for Technical Regulation and Accreditation  
Tel: +7(495)669 -24-00  
Fax: +7(495)669 -24-15  
E-mail: dept_techregulation@eurasiancommissio n.org   
Website: www.eurasiancommission.org   
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding t he notification shall be indicated if different from above:   
Russian Scientific and Technical Center for Information on Standardization, Metrology 
and Conformity Assessment  
(Standartinform, National enquiry point for the TBT Agreement)  
Tel: +7(495) 531 -26-59  
E-mail: info@gostinfo.ru   
Website: www.gostinfo.ru   
3. Notified under Article 2.9.2 [   ], 2.10.1 [   ], 5.6.2 [X], 5.7.1 [   ], other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Medicinal 
products  
5. Title, number of pages and language(s) of the notified document:  Draft 
amendments to the Rules for conducting pharmaceut ical inspections (10 page(s), in 
Russian)  
6. Description of content:  The draft amendments to the Rules for conducting 
pharmaceutical inspections set out the unified approaches to carry out pharmaceutical 
inspections, including the use of remote communicat ion (for instance, via audio or video) 
by decision of the pharmaceutical inspectorate of a Member State of the Eurasian 
Economic Union in the following conditions:  
- threats of occurrence and elimination of an emergency situation and (or) in case of a 
threat of the spread of epidemic diseases that pose a danger to others, diseases and 
injuries resulting from exposure to adverse chemical, biological, radiation factors;  
- the occurrence of majeure circumstances or circumstances beyond the control of the 
parties that may cause harm to inspectors'   health and lives (for instance, for medical or 
other reasons).  G/TBT/N/RUS/129  
 
- 2 - 
 
  7. Objective and rationale, including the nature of urgent problems where 
applicable:  Prevention of deceptive practices and consumer protection; Pro tection of 
human health or safety; Reducing trade barriers and facilitating trade  
8. Relevant documents:   
Draft amendments to the Rules for conducting pharmaceutical inspections  
http://docs.eaeunion.org/ria/ru -ru/0105192/ria_05032022  
9. Proposed date of adoption:  To be determined  
Proposed date of entry into force:  To be determined  
10. Final date for comments:  9 April 2022  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
Eurasian Economic Commission  
Department for Technical Regulation and Accreditation  
Tel: +7(495)669 -24-00  
Fax: +7(495)669 -24-15  
E-mail: dept_techregulation@eurasiancommission.org   
Website: www.eurasiancommission.org  
 
Russian Scientific and Technical Center for Information on Standardization, Metrology 
and Conformity Assessment  
(Standartinform, National enquiry point for the TBT Agreement)  
Tel: +7(495) 531 -26-59  
E-mail: info@gostinfo.ru   
Website: www.gostinfo.ru   
 
 http://docs.eaeunion.org/ria/r u-ru/0105192/ria_05032022